BMRN vs EXPE · P/E 40, rev $1.76B vs P/E 20, rev $7.74B
Biomarin Pharmaceutical Inc (BMRN) versus Expedia Group Inc. (EXPE) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Expedia Group Inc. (EXPE) is a travel services company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported EXPE revenue for 2026-06-30 was $7.74B. Net income was $872.0M. EXPE currently screens at market cap $21.71B and trailing P/E 20.4.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. EXPE currently screens at market cap $21.71B and trailing P/E 20.4.
Not investment advice. Open the BMRN and EXPE stock pages for the full models.
Not investment advice.